Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	44
Overall Study	STARTED	BOTOX 50 U	57
Overall Study	STARTED	BOTOX 100 U	54
Overall Study	STARTED	BOTOX 150 U	49
Overall Study	STARTED	BOTOX 200 U	53
Overall Study	STARTED	BOTOX 300 U	56
Overall Study	COMPLETED	Placebo	37
Overall Study	COMPLETED	BOTOX 50 U	50
Overall Study	COMPLETED	BOTOX 100 U	48
Overall Study	COMPLETED	BOTOX 150 U	40
Overall Study	COMPLETED	BOTOX 200 U	47
Overall Study	COMPLETED	BOTOX 300 U	50
Overall Study	NOT COMPLETED	Placebo	7
Overall Study	NOT COMPLETED	BOTOX 50 U	7
Overall Study	NOT COMPLETED	BOTOX 100 U	6
Overall Study	NOT COMPLETED	BOTOX 150 U	9
Overall Study	NOT COMPLETED	BOTOX 200 U	6
Overall Study	NOT COMPLETED	BOTOX 300 U	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00168454/flow